Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS
NCT07455500
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndrome
Interventions
OTHER:
Bone marrow and blood sampling
Sponsor
University Hospital, Grenoble